about
Interplay of DNA methyltransferase 1 and EZH2 through inactivation of Stat3 contributes to β-elemene-inhibited growth of nasopharyngeal carcinoma cells3,3'-Diindolylmethane inhibits the invasion and metastasis of nasopharyngeal carcinoma cells in vitro and in vivo by regulation of epithelial mesenchymal transitionStat3 inhibitor Stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinomaInvolvement of microRNA-24 and DNA methylation in resistance of nasopharyngeal carcinoma to ionizing radiationQuantitative expression analysis and prognostic significance of the BCL2-associated X gene in nasopharyngeal carcinoma: a retrospective cohort study.Curcumin analogue T83 exhibits potent antitumor activity and induces radiosensitivity through inactivation of Jab1 in nasopharyngeal carcinomaMonocyte chemotactic protein 1 (MCP-1) modulates pro-survival signaling to promote progression of head and neck squamous cell carcinoma.Targeted inhibition of the COP9 signalosome for treatment of cancerHsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3'UTR and 5'UTR of Jab1/CSN5.Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression.Emerging roles of Jab1/CSN5 in DNA damage response, DNA repair, and cancer.Evodiamine inhibits the migration and invasion of nasopharyngeal carcinoma cells in vitro via repressing MMP-2 expression.Reverse correlation of Jab1 and Smad4 in PANC-1 cells involved in the pathogenesis of pancreatic cancerThe emerging roles of Jab1/CSN5 in cancer.Increased Jab1/COPS5 is associated with therapeutic response and adverse outcome in lung cancer and breast cancer patients.CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing β-Catenin Ubiquitination.Analysis of differential gene expression profile identifies novel biomarkers for breast cancer.Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer.KAI1/CD82 Genetically Engineered Endothelial Progenitor Cells Inhibit Metastasis of Human Nasopharyngeal Carcinoma in a Mouse Model.
P2860
Q33674025-C3FB5F3B-7373-41D6-8752-4B85B7C5B21EQ33706155-B0616069-E60D-42B0-835D-BD9A5B11AECBQ34575479-AD485225-47BE-4467-9D75-A50023BB113FQ34646522-EC4757E1-0C4F-4B9F-961F-723406A76C5DQ34777413-6CFEF59C-0AE1-4962-9C9D-761762F0F149Q34788446-7B8CBEDC-4F9B-410D-997C-289F2B8F4E40Q35106460-AF6404A9-EB0E-4C3F-A39B-A59ECA7D29AEQ37364323-2C7477C0-8D9D-48A7-A339-2509DCD23439Q37404858-65A415DE-CBDB-478A-8D0A-DA2E10C84FA8Q37643955-24659215-8CF4-4134-816C-5CC3A01364BEQ37683027-3273E0D7-CB52-4FB4-82F4-F34C8974A344Q38821356-DA5ADE7D-2CB1-465A-9379-4342EDB1E860Q38828037-FBFC7524-7E37-407D-B535-6CC8DD74E8FFQ38842175-C24685C9-E488-42A5-BBA2-AA6CD4A25FBAQ47153479-5FB5B904-34EC-457B-8F64-485C2C3ADAABQ47347572-27097597-C692-47E9-B4B5-BB4FFE95869DQ49188421-596F23D0-F94D-4D52-B4D4-098A01ACC7B6Q52657204-7F7DAAE0-A988-4436-807F-DF34647F2869Q54946915-0EAFE020-244A-4717-B594-4D9CFF6073B6
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Targeting Jab1/CSN5 in nasopharyngeal carcinoma
@ast
Targeting Jab1/CSN5 in nasopharyngeal carcinoma
@en
type
label
Targeting Jab1/CSN5 in nasopharyngeal carcinoma
@ast
Targeting Jab1/CSN5 in nasopharyngeal carcinoma
@en
prefLabel
Targeting Jab1/CSN5 in nasopharyngeal carcinoma
@ast
Targeting Jab1/CSN5 in nasopharyngeal carcinoma
@en
P2860
P1433
P1476
Targeting Jab1/CSN5 in nasopharyngeal carcinoma
@en
P2093
Francois X Claret
Yunbao Pan
P2860
P304
P356
10.1016/J.CANLET.2012.07.033
P407
P577
2012-08-04T00:00:00Z